References
- Counago F, Rodriguez de Dios N, Montemuino S, et al. Neoadjuvant treatment followed by surgery versus definitive chemoradiation in stage IIIA-N2 non-small-cell lung cancer: a multi-institutional study by the oncologic group for the study of lung cancer (Spanish Radiation Oncology Society). Lung Cancer 2018;118:119-27. https://doi.org/10.1016/j.lungcan.2018.02.008
- Eichhorn F, Klotz LV, Bischoff H, et al. Neoadjuvant anti-programmed death-1 immunotherapy by Pembrolizumab in resectable nodal positive stage II/IIIa non-small-cell lung cancer (NSCLC): the NEOMUN trial. BMC Cancer 2019;19:413. https://doi.org/10.1186/s12885-019-5624-2
- Yang CJ, Gu L, Shah SA, et al. Long-term outcomes of surgical resection for stage IV non-small-cell lung cancer: a national analysis. Lung Cancer 2018;115:75-83. https://doi.org/10.1016/j.lungcan.2017.11.021
- Detterbeck FC. The eighth edition TNM stage classification for lung cancer: what does it mean on main street? J Thorac Cardiovasc Surg 2018;155:356-9. https://doi.org/10.1016/j.jtcvs.2017.08.138
- Shimizu K, Yoshida J, Nagai K, et al. Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer. J Thorac Cardiovasc Surg 2005;130:160-5. https://doi.org/10.1016/j.jtcvs.2004.11.021
- Huang H, Wang T, Hu B, Pan C. Visceral pleural invasion remains a size-independent prognostic factor in stage I non-small cell lung cancer. Ann Thorac Surg 2015;99:1130-9. https://doi.org/10.1016/j.athoracsur.2014.11.052
- Yamanashi K, Menju T, Hamaji M, et al. Prognostic factors related to postoperative survival in the newly classified clinical T4 lung cancer. Eur J Cardiothorac Surg 2020;57:754-61. https://doi.org/10.1093/ejcts/ezz288
- Galetta D, Borri A, Casiraghi M, et al. Outcome and prognostic factors of resected non-small-cell lung cancer invading the diaphragm. Interact Cardiovasc Thorac Surg 2014;19:632-6. https://doi.org/10.1093/icvts/ivu183
- Reardon ES, Schrump DS. Extended resections of non-small cell lung cancers invading the aorta, pulmonary artery, left atrium, or esophagus: can they be justified? Thorac Surg Clin 2014;24:457-64. https://doi.org/10.1016/j.thorsurg.2014.07.012
- Liu M, Wigle D, Wampfler JA, et al. T category of non-small cell lung cancer invading the fissure to the adjacent lobe. J Thorac Cardiovasc Surg 2017;154:1777-83. https://doi.org/10.1016/j.jtcvs.2017.07.069
- Yang HX, Hou X, Lin P, et al. Peripheral direct adjacent lobe invasion non-small cell lung cancer has a similar survival to that of parietal pleural invasion T3 disease. J Thorac Oncol 2009;4:1342-6. https://doi.org/10.1097/jto.0b013e3181bbb284
- Mikubo M, Nakashima H, Naito M, et al. Prognostic impact of uncertain parietal pleural invasion at adhesion sites in non-small cell lung cancer patients. Lung Cancer 2017;108:103-8. https://doi.org/10.1016/j.lungcan.2017.03.002
- Shimada Y, Saji H, Yoshida K, et al. Pathological vascular invasion and tumor differentiation predict cancer recurrence in stage IA non-small-cell lung cancer after complete surgical resection. J Thorac Oncol 2012;7:1263-70. https://doi.org/10.1097/jto.0b013e31825cca6e
- Tsutani Y, Suzuki K, Koike T, et al. High-risk factors for recurrence of stage I lung adenocarcinoma: follow-up data from JCOG0201. Ann Thorac Surg 2019;108:1484-90. https://doi.org/10.1016/j.athoracsur.2019.05.080
- Samejima J, Yokose T, Ito H, et al. Prognostic significance of blood and lymphatic vessel invasion in pathological stage IA lung adenocarcinoma in the 8th edition of the TNM classification. Lung Cancer 2019;137:144-8. https://doi.org/10.1016/j.lungcan.2019.09.022
- Strauss GM, Herndon JE, Maddaus MA, et al. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. J Clin Oncol 2008;26:5043-51. https://doi.org/10.1200/jco.2008.16.4855
- Park SY, Lee JG, Kim J, et al. Efficacy of platinum-based adjuvant chemotherapy in T2aN0 stage IB non-small cell lung cancer. J Cardiothorac Surg 2013;8:151. https://doi.org/10.1186/1749-8090-8-151
- Tsutani Y, Miyata Y, Kushitani K, Takeshima Y, Yoshimura M, Okada M. Propensity score-matched analysis of adjuvant chemotherapy for stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2014;148:1179-85. https://doi.org/10.1016/j.jtcvs.2014.05.084
- Hamada C, Tsuboi M, Ohta M, et al. Effect of postoperative adjuvant chemotherapy with tegafur-uracil on survival in patients with stage IA non-small cell lung cancer: an exploratory analysis from a meta-analysis of six randomized controlled trials. J Thorac Oncol 2009;4:1511-6. https://doi.org/10.1097/jto.0b013e3181bbf1f2
- Kim HJ, Cho JY, Lee YJ, et al. Clinical significance of pleural attachment and indentation of subsolid nodule lung cancer. Cancer Res Treat 2019;51:1540-8. https://doi.org/10.4143/crt.2019.057